Hypertrophic cardiomyopathy electrocardiogram: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
==Stress Test== | |||
===2011 ACCF/AHA Guideline Recommendations: Stress Testing <ref name="pmid22075468">{{cite journal |author=Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, Seidman CE, Towbin JA, Udelson JE, Yancy CW |title=2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons |journal=[[Journal of the American College of Cardiology]] |volume=58 |issue=25 |pages=2703–38 |year=2011 |month=December |pmid=22075468 |doi=10.1016/j.jacc.2011.10.825 |url=http://linkinghub.elsevier.com/retrieve/pii/S0735-1097(11)04383-X |accessdate=2011-12-19}}</ref><ref name="pmid22075469">{{cite journal |author=Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, Seidman CE, Towbin JA, Udelson JE, Yancy CW |title=2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons |journal=[[Journal of the American College of Cardiology]] |volume=58 |issue=25 |pages=e212–60 |year=2011 |month=December |pmid=22075469 |doi=10.1016/j.jacc.2011.06.011 |url=http://linkinghub.elsevier.com/retrieve/pii/S0735-1097(11)02275-3 |accessdate=2011-12-19}}</ref>=== | |||
{{cquote| | |||
====[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class IIa]]==== | |||
'''1.''' Treadmill exercise testing is reasonable to determine functional capacity and response to therapy in patients with [[HOCM]]. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])'' | |||
'''2.''' Treadmill testing with monitoring of an ECG and blood pressure is reasonable for [[Hypertrophic cardiomyopathy risk factors for sudden death|SCD risk stratification]] in patients with [[HOCM]].<ref name="pmid9386166">{{cite journal |author=Sadoul N, Prasad K, Elliott PM, Bannerjee S, Frenneaux MP, McKenna WJ |title=Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy |journal=[[Circulation]] |volume=96 |issue=9 |pages=2987–91 |year=1997 |month=November |pmid=9386166 |doi= |url=http://circ.ahajournals.org/cgi/pmidlookup?view=long&pmid=9386166 |accessdate=2011-12-22}}</ref><ref name="pmid10362212">{{cite journal |author=Olivotto I, Maron BJ, Montereggi A, Mazzuoli F, Dolara A, Cecchi F |title=Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy |journal=[[Journal of the American College of Cardiology]] |volume=33 |issue=7 |pages=2044–51 |year=1999 |month=June |pmid=10362212 |doi= |url=http://linkinghub.elsevier.com/retrieve/pii/S0735-1097(99)00094-7 |accessdate=2011-12-22}}</ref><ref name="pmid12106932">{{cite journal |author=Ciampi Q, Betocchi S, Lombardi R, Manganelli F, Storto G, Losi MA, Pezzella E, Finizio F, Cuocolo A, Chiariello M |title=Hemodynamic determinants of exercise-induced abnormal blood pressure response in hypertrophic cardiomyopathy |journal=[[Journal of the American College of Cardiology]] |volume=40 |issue=2 |pages=278–84 |year=2002 |month=July |pmid=12106932 |doi= |url=http://linkinghub.elsevier.com/retrieve/pii/S0735109702019502 |accessdate=2011-12-22}}</ref> ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])'' | |||
'''3.''' In patients with [[HOCM]] who do not have a resting peak instantaneous gradient of greater than or equal to 50 mm Hg, [[Exercise stress testing#Exercise/Pharmacologic Stress Echocardiography|exercise echocardiography]] is reasonable for the detection and quantification of exercise-induced dynamic LVOT obstruction.<ref name="pmid17088454">{{cite journal |author=Maron MS, Olivotto I, Zenovich AG, Link MS, Pandian NG, Kuvin JT, Nistri S, Cecchi F, Udelson JE, Maron BJ |title=Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction |journal=[[Circulation]] |volume=114 |issue=21 |pages=2232–9 |year=2006 |month=November |pmid=17088454 |doi=10.1161/CIRCULATIONAHA.106.644682 |url=http://circ.ahajournals.org/cgi/pmidlookup?view=long&pmid=17088454 |accessdate=2011-12-22}}</ref><ref name="pmid2242524">{{cite journal |author=Frenneaux MP, Counihan PJ, Caforio AL, Chikamori T, McKenna WJ |title=Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy |journal=[[Circulation]] |volume=82 |issue=6 |pages=1995–2002 |year=1990 |month=December |pmid=2242524 |doi= |url=http://circ.ahajournals.org/cgi/pmidlookup?view=long&pmid=2242524 |accessdate=2011-12-22}}</ref><ref name="pmid9386166">{{cite journal |author=Sadoul N, Prasad K, Elliott PM, Bannerjee S, Frenneaux MP, McKenna WJ |title=Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy |journal=[[Circulation]] |volume=96 |issue=9 |pages=2987–91 |year=1997 |month=November |pmid=9386166 |doi= |url=http://circ.ahajournals.org/cgi/pmidlookup?view=long&pmid=9386166 |accessdate=2011-12-22}}</ref><ref name="pmid10362212">{{cite journal |author=Olivotto I, Maron BJ, Montereggi A, Mazzuoli F, Dolara A, Cecchi F |title=Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy |journal=[[Journal of the American College of Cardiology]] |volume=33 |issue=7 |pages=2044–51 |year=1999 |month=June |pmid=10362212 |doi= |url=http://linkinghub.elsevier.com/retrieve/pii/S0735-1097(99)00094-7 |accessdate=2011-12-22}}</ref> ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])''}} | |||
==References== | ==References== | ||
Revision as of 14:26, 1 October 2012
|
Hypertrophic Cardiomyopathy Microchapters |
|
Differentiating Hypertrophic Cardiomyopathy from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hypertrophic cardiomyopathy electrocardiogram On the Web |
|
Directions to Hospitals Treating Hypertrophic cardiomyopathy |
|
Risk calculators and risk factors for Hypertrophic cardiomyopathy electrocardiogram |
Editors-In-Chief: C. Michael Gibson, M.S., M.D. [1], Martin S. Maron, M.D., and Barry J. Maron, M.D.
Overview
Stress Test
2011 ACCF/AHA Guideline Recommendations: Stress Testing [1][2]
| “ |
Class IIa1. Treadmill exercise testing is reasonable to determine functional capacity and response to therapy in patients with HOCM. (Level of Evidence: C) 2. Treadmill testing with monitoring of an ECG and blood pressure is reasonable for SCD risk stratification in patients with HOCM.[3][4][5] (Level of Evidence: B) 3. In patients with HOCM who do not have a resting peak instantaneous gradient of greater than or equal to 50 mm Hg, exercise echocardiography is reasonable for the detection and quantification of exercise-induced dynamic LVOT obstruction.[6][7][3][4] (Level of Evidence: B) |
” |
References
- ↑ Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, Seidman CE, Towbin JA, Udelson JE, Yancy CW (2011). "2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons". Journal of the American College of Cardiology. 58 (25): 2703–38. doi:10.1016/j.jacc.2011.10.825. PMID 22075468. Retrieved 2011-12-19. Unknown parameter
|month=ignored (help) - ↑ Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, Seidman CE, Towbin JA, Udelson JE, Yancy CW (2011). "2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons". Journal of the American College of Cardiology. 58 (25): e212–60. doi:10.1016/j.jacc.2011.06.011. PMID 22075469. Retrieved 2011-12-19. Unknown parameter
|month=ignored (help) - ↑ 3.0 3.1 Sadoul N, Prasad K, Elliott PM, Bannerjee S, Frenneaux MP, McKenna WJ (1997). "Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy". Circulation. 96 (9): 2987–91. PMID 9386166. Retrieved 2011-12-22. Unknown parameter
|month=ignored (help) - ↑ 4.0 4.1 Olivotto I, Maron BJ, Montereggi A, Mazzuoli F, Dolara A, Cecchi F (1999). "Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy". Journal of the American College of Cardiology. 33 (7): 2044–51. PMID 10362212. Retrieved 2011-12-22. Unknown parameter
|month=ignored (help) - ↑ Ciampi Q, Betocchi S, Lombardi R, Manganelli F, Storto G, Losi MA, Pezzella E, Finizio F, Cuocolo A, Chiariello M (2002). "Hemodynamic determinants of exercise-induced abnormal blood pressure response in hypertrophic cardiomyopathy". Journal of the American College of Cardiology. 40 (2): 278–84. PMID 12106932. Retrieved 2011-12-22. Unknown parameter
|month=ignored (help) - ↑ Maron MS, Olivotto I, Zenovich AG, Link MS, Pandian NG, Kuvin JT, Nistri S, Cecchi F, Udelson JE, Maron BJ (2006). "Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction". Circulation. 114 (21): 2232–9. doi:10.1161/CIRCULATIONAHA.106.644682. PMID 17088454. Retrieved 2011-12-22. Unknown parameter
|month=ignored (help) - ↑ Frenneaux MP, Counihan PJ, Caforio AL, Chikamori T, McKenna WJ (1990). "Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy". Circulation. 82 (6): 1995–2002. PMID 2242524. Retrieved 2011-12-22. Unknown parameter
|month=ignored (help)